17 July 2024 : Clinical Research
Prognostic Impact of Tumor-Infiltrating Immune Cells on Efficacy of Neoadjuvant Chemotherapy in Patients with Advanced or Metastatic Ovarian Cancer: A Retrospective Study
Qunxian Rao1BCE, Miaoling Huang1B, Meimei Guan1C, Changhao Liu1D, Lijuan Wang1D, Zhongqiu Lin1A*, Qing Chen1ADOI: 10.12659/MSM.943170
Med Sci Monit 2024; 30:e943170
Figure 5 The difference of TIIC subsets post-NACT between patients with benefit and those with no/part benefit(A) The difference of stromal CD68+CD163+ cells post-NACT; (B) The difference of stromal CD8+ cells; (C) The difference of stromal CD8+PD-1+ cells; (D) The difference of intratumoral CD3+PD-1+ cells. TIIC – tumor-infiltration immune cells; NACT – neoadjuvant chemotherapy. Figure 5 was plotted by R version 4.0.0 (https://www.r-project.org/).